person

Miguel R.

Country
Spain
Department
NA

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 47 partner sites.

Specializations

Oncology – Advanced Solid Tumours

The investigator concentrates on solid tumours that are advanced or metastatic across a range of organ systems.

  • Breast cancer (hormone‑receptor positive, HER2‑negative, triple‑negative)
  • Non‑small cell lung cancer (including KRAS‑mutated and EGFR‑mutated subtypes)
  • Renal cell carcinoma (clear‑cell and non‑clear‑cell)
  • Colorectal cancer (including KRAS G12C‑mutated disease)
  • Urothelial carcinoma (both ICI‑naïve and ICI‑experienced)

Clinical activity is coordinated through Hospital Clínico San Carlos in Madrid.

Cardiovascular Medicine

Research efforts target major cardiovascular disorders with a focus on atherosclerotic disease and acute events.

  • Atherosclerotic cardiovascular disease (including elevated lipoprotein(a))
  • Acute coronary syndrome and myocardial infarction
  • Heart failure (reduced, mildly reduced, and preserved ejection fraction)
  • Atrial fibrillation and post‑PCI management
  • Acute pulmonary embolism and venous thromboembolism

Studies often involve patients with established cardiovascular risk profiles.

Neurology – Neurodegenerative and Seizure Disorders

The investigator engages in trials addressing neurological diseases that impact cognition and motor function.

  • Alzheimer’s disease (early and pre‑clinical stages)
  • Multiple sclerosis (relapsing and progressive forms)
  • Epilepsy (focal onset and generalized seizures)
  • Acute ischemic stroke and high‑risk transient ischemic attack
  • Parkinson’s disease related fatigue and non‑motor symptoms

Therapeutic strategies include disease‑modifying agents and symptomatic treatments.

Immunology and Autoimmune Disorders

Focus is placed on chronic immune‑mediated conditions that require targeted immunotherapies.

  • Systemic lupus erythematosus
  • Atopic dermatitis
  • Psoriasis (moderate‑to‑severe plaque disease)
  • Chronic spontaneous urticaria
  • Allergic rhinitis and rhinoconjunctivitis

Investigations often evaluate biologic agents that modulate specific cytokine pathways.

Infectious Diseases

Clinical work includes trials for serious infectious diseases affecting diverse patient populations.

  • COVID‑19 (including severe community‑acquired pneumonia)
  • Bacterial pneumonia (hospital‑acquired and ventilator‑associated)
  • Human immunodeficiency virus infection and prophylaxis
  • Influenza and other respiratory viral infections
  • Meningococcal disease

These studies aim to improve outcomes through novel antivirals, vaccines, and antimicrobial strategies.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.